2017
DOI: 10.1007/s00059-017-4564-3
|View full text |Cite
|
Sign up to set email alerts
|

Cerebral dopamine neurotrophic factor protects H9c2 cardiomyocytes from apoptosis

Abstract: The findings presented here contribute toward identifying the physiological functions of CDNF in cardiovascular diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 34 publications
0
7
0
Order By: Relevance
“…In ER stress-related disease models in vivo, expression of endogenous CDNF was reported to increase after cerebral or myocardial ischemia [ 67 , 68 ]. In vitro, ER stress-inducing tunicamycin treatment increased CDNF expression in cardiomyocytes [ 69 ] but not in an osteosarcoma-derived cell line [ 58 ]. Thus, responsiveness of CDNF to ER stress may depend on cell type.…”
Section: Introductionmentioning
confidence: 99%
“…In ER stress-related disease models in vivo, expression of endogenous CDNF was reported to increase after cerebral or myocardial ischemia [ 67 , 68 ]. In vitro, ER stress-inducing tunicamycin treatment increased CDNF expression in cardiomyocytes [ 69 ] but not in an osteosarcoma-derived cell line [ 58 ]. Thus, responsiveness of CDNF to ER stress may depend on cell type.…”
Section: Introductionmentioning
confidence: 99%
“…But for CDNF, there has not found any ER stress response element in the CDNF promoter and little significant found has been reported about the effect of CDNF in ER stress. Our recently study has found that CDNF expression can be upregulated by tunicamycin in H9c2 cells and CDNF overexpression can protect H9c2 cells from apoptosis induced by tunicamycin (in press) (Liu et al, ). But whether this protective role of CDNF on H9c2 is related with ER stress still need more studies.…”
Section: Discussionmentioning
confidence: 99%
“…Although MANF and CDNF were initially discovered by their neurotrophic activities, further studies revealed that MANF and CDNF are highly expressed in non-neural tissues and that their cytoprotective activity extends beyond the dopaminergic system ( Tadimalla et al, 2008 , Airavaara et al, 2009 ; Glembotski et al, 2012 ; Lindahl et al, 2014 ; Yang et al, 2014 ; Neves et al, 2016 ; Gao et al, 2017 ; Liu et al, 2018 ; Lu et al, 2018 ; Matlik et al, 2018 ). Moreover, MANF is found in circulation in the blood and it has been associated with several non-neuronal diseases in humans, including inflammatory diseases ( Wang et al, 2014 ; Chen et al, 2015 ; Yavarna et al, 2015 ; Galli et al, 2016 ), suggesting a role beyond neuroprotection.…”
Section: Manf and Cdnf In Immune Cell Signalingmentioning
confidence: 99%
“…MANF and CDNF were initially discovered by their neuroprotective activities in dopaminergic neurons in vitro and in vivo ( Petrova et al, 2003 ; Lindholm et al, 2007 ; Voutilainen et al, 2009 ) and thus classified as NTFs. However, these molecules are structurally distinct from all other classes of NTFs, signal through a yet unknown receptor/mechanism ( Lindahl et al, 2017 ) and their physiological activity extends beyond the nervous system ( Tadimalla et al, 2008 ; Glembotski et al, 2012 ; Lindahl et al, 2014 ; Chen et al, 2015 ; Liu et al, 2018 ). Moreover, similarly, to what has been found for neuropoietic cytokines, MANF and CDNF also play important roles in the regulation of immune responses ( Zhao et al, 2014 ; Chen et al, 2015 ; Neves et al, 2016 ) and this immune modulatory function is essential for their biological activity in vivo , promoting neuroprotection and regenerative success ( Neves et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%